Interferences with cardiac biomarker assays: understanding the clinical impact.

Nevraumont, Arnaud; Deltombe, Matthieu; Favresse, Julien; Guillaume, Louise; Chapelle, Virginie; Twerenbold, Raphael; Gruson, Damien

Nevraumont, Arnaud; Deltombe, Matthieu; Favresse, Julien; Guillaume, Louise; Chapelle, Virginie; Twerenbold, Raphael; Gruson, Damien.

Afiliación

Nevraumont A; Department of Clinical Biochemistry, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium.
Deltombe M; Department of Clinical Biochemistry, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium.
Favresse J; Department of Laboratory Medicine, Clinique Saint-Luc, Bouge, Belgium.
Guillaume L; Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium.
Chapelle V; Department of Clinical Biochemistry, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium.
Twerenbold R; Department of Clinical Biochemistry, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium.
Gruson D; Department of Cardiology and University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, Hamburg, Germany.

Eur Heart J ; 43(24): 2286-2288, 2022 06 21.

Article en En | MEDLINE | ID: mdl-35084447

Asunto(s)

Biomarcadores; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biomarcadores Límite: Humans Idioma: En Revista: Eur Heart J Año: 2022 Tipo del documento: Article País de afiliación: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google